Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients

International Immunopharmacology

Volumn 9, Issue 1, 2009, Pages 26-31

  Nogueira, Eliana ^a   Ozaki, Kikumi Suzete ^a   Tomiyama, Helena ^a   Câmara, Niels Olsen Saraiva ^a,b   Granato, Celso Francisco Hernandes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytomegalovirus; Genotyping; pp65 antigenemia; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIGEN PP65; FINGOLIMOD; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; VIRUS DNA;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DISEASE MARKER; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; SYMPTOMATOLOGY; VIRUS GENE; VIRUS GENE GB1; VIRUS GENE GB1V; VIRUS GENE GB2; VIRUS GENE GB4; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEUTROPHILS; PHOSPHOPROTEINS; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRAL LOAD; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 58149472592     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.08.020     Document Type: Article

References (35)

1. Aquino V.H., and Figueiredo L.T. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 61 (2000) 138-142
2. Zweygberg-Wirgart B., Brytting M., Linde A., Wahren B., and Grillner L. Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol 36 (1998) 3662-3669
3. Sagedal S., Nordal K.P., Hartmann A., Sund S., Scott H., Degré M., Foss A., et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant (2002) 850-856
4. Novella J.L., Lavaud S., Wynckel A., Jolly D., and Chanard J. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transplant Int 13 (2000) 413-419
5. Humar A., Gillingham KJ Payne W.D., Dunn D.L., Sutherland S.E.R., and Matas A.J. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipient. Transplantation 68 (1999) 879-1883
6. Opelz G., Dohler B., and Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 6 (Jun 2004) 928-936
7. Dickenmann M.J., Cathomas G., Steiger J., Mihatsch M.J., Thiel G., and Tamm M. Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation 71 (2001) 764-767
8. Hibberd 199208 Hibberd P.L., Tolkoff-Rubin N.E., Cosimi A.B., Schooley R.T., Isaacson D., Doran M., et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 53 1 (Jan 1992) 68-72
9. Singh J., and Compton T. Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B. J Virol 74 (2000) 1383-1392
10. Navarro D., Paz P., Tugizov S., Topp K., La Vail J., and Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197 (1993) 143-158
11. Chou S.W. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis 162 (1990) 738-742
12. Chou S.W., and Dennison K.M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163 (1991) 1229-1234
13. Binder T., Siegert W., Kruse A., Oettle H., Wilborn F., Peng R., et al. Identification of human cytomegalovirus variants by analysis of single strand conformation polymorphism and DNA sequencing of the envelope glycoprotein B gene region-distribution frequency in liver transplant recipients. J Virol Methods 78 (1999) 153-162
14. Pacsa 200314 Pacsa A.S., Essa S., Voevodin A., el-Shazly A., Kazak H., Nampoory M.R., et al. Correlation between CMV genotypes, multiple infections with herpesviruses (HHV-6, 7) and development of CMV disease in kidney recipients in Kuwait. FEMS Immunol Med Microbiol 35 2 (Mar 20 2003) 125-130
15. Fries B.C., Chou S., Boeckh M., and Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 169 (1994) 769-774
16. Torok-Storb B., Boeckh M., Hoy C., Leisenring W., Myerson D., and Gooley T. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90 (1997) 2097-2102
17. Bale J.F., Petheram Jr. S.J., Robertson M., Murph J.R., and Demmler G. Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 65 (2001) 90-96
18. Sarcinella L., Mazzulli T., Willey B., and Humar A. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol 24 (2002) 99-105
19. Vogelberg C., Meyer-Konig U., Hufert F.T., Kirste G., and von Laer D. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 50 (1996) 31-34
20. Woo P.C., Lo C.Y., Lo S.K., Siau H., Peiris J.S., Wong S.S., et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 4 (1997) 515-518
21. Shepp D.H., Match M.E., Ashraf A.B., Lipson S.M., Millan C., and Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 174 (1996) 184-187
22. Peek R., Verbraak F., Bruinenberg M., Van der Lelij A., Van den Horn G., and Kijlstra A. Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis. Invest Ophthalmol Vis Sci 39 (1998) 1183-1187
23. Ozaki K.S., Pestana J.O., Granato C.F., Pacheco-Silva A., and Camargo L.F. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies. Transpl Infect Dis 6 2 (Jun 2004) 63-68
24. Boeckh M., Bowden R.A., Gooley T., Myerson D., and Corey L. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 93 5 (Mar 1 1999) 1781-1782
25. van der Bij W., Torensma R., van Son W.J., Anema J., Schirm J., Tegzess A.M., et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 25 (1988) 179-188
26. Trincado D.E., Scott G.M., White P.A., Hunt C., Rasmussen L., and Rawlinson W.D. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 61 (2000) 481-487
27. Meyer-Konig U., Vogelberg C., Bongarts A., Kampa D., Delbruck R., Wolff-Vorbeck G., et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55 (1998) 75-81
28. Rasmussen L., Hong C., Zipeto D., Morris S., Sherman D., Chou S., et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 175 (1997) 179-184
29. Lukacsi A., Tarodi B., Endreffy E., Babinszki A., Pal A., and Pusztai R. Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. J Med Virol 65 (2001) 537-542
30. Meyer-Konig U., Haberland M., von Laer D., Haller O., and Hufert F.T. Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 177 (1998) 1162-1169
31. Gilbert C., Handfield J., Toma E., Lalonde R., Bergeron M.G., and Boivin G. Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 59 (1999) 98-103
32. Drew W.L., Chou S., Miner R.C., Mohr B.A., Busch M.P., van der Horst C.M., et al. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 186 (2002) 114-117
33. Bale Jr. J.F., Murph J.R., Demmler G.J., Dawson J., Miller J.E., and Petheram S.J. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 182 3 (Sep 2000) 933-936
34. Marin L.J., Cunha A.A., Aquino V.H., and Figueiredo L.T.F. The use of qualitative and quantitative polymerase chain reactions for diagnosis of cytomegalovirus infections in bone marrow and kidney transplant recipients. Rev Soc Bras Med Trop 37 2 (2004) 158-164
35. Caliendo A.M., George K.S., Allega J., Bullotta A.C., Gilbane L., and Rinaldo C.R. Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assay. J Clin Microbiol 40 5 (2002) 1581-1586